Procter & Gamble Reaffirms FY14 guidance EPS +5-7% (implies $4.05-4.13 v $4.29e), Rev (incl fx impact) +3-4% (implies $84.6-85.4B v $85.7Be)
Procter & Gamble Reaffirms FY14 guidance EPS +5-7% (implies $4.05-4.13 v $4.29e), Rev (incl fx impact) +3-4% (implies $84.6-85.4B v $85.7Be)